0000899243-17-024252.txt : 20171016
0000899243-17-024252.hdr.sgml : 20171016
20171016170750
ACCESSION NUMBER: 0000899243-17-024252
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171013
FILED AS OF DATE: 20171016
DATE AS OF CHANGE: 20171016
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chern Carey
CENTRAL INDEX KEY: 0001688374
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19825
FILM NUMBER: 171139316
MAIL ADDRESS:
STREET 1: 950 TOWER LANE, SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000880771
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943116852
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
BUSINESS PHONE: 650-358-3456
MAIL ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-10-13
1
0000880771
SCICLONE PHARMACEUTICALS INC
SCLN
0001688374
Chern Carey
950 TOWER LANE, SUITE 900
FOSTER CITY
CA
94404
0
1
0
0
General Counsel
Common Stock
2017-10-13
4
M
0
30000
A
31982
D
Common Stock
2017-10-13
4
F
0
11274
11.18
D
20708
D
Common Stock
2017-10-13
4
D
0
20708
11.18
A
0
D
Incentive Stock Option (right to buy)
10.35
2017-10-13
4
D
0
38644
0.83
D
2026-11-14
Common Stock
38644
0
D
Non-Qualified Stock Option (right to buy)
10.35
2017-10-13
4
D
0
41356
0.83
D
2026-11-14
Common Stock
41356
0
D
Restricted Stock Unit
2017-10-13
4
M
0
30000
D
Common Stock
30000
0
D
Each restricted stock unit represented a contingent right to receive one share of SCLN common stock upon settlement.
Includes 773 shares of SCLN common stock acquired under Issuer's 2016 Employee Stock Purchase Plan on May 31, 2017; 746 shares of SCLN common stock acquired under Issuer's 2016 Employee Stock Purchase Plan on August 31, 2017; and 463 shares of SCLN common stock acquired under Issuer's 2016 Employee Stock Purchase Plan on October 6, 2017.
Granted under Issuer's 2015 Equity Incentive Plan.
Under its terms the option became exercisable in installments with 25% vesting on October 24, 2017 and 2.0833% vesting each month thereafter until it became vested in full immediately prior to the merger of Issuer and Silver Delaware Investment Limited (the "Merger").
The option was canceled immediately prior to the Merger in exchange for a cash payment per share from the Issuer in an amount equal to the excess of $11.18 per share over the exercise price.
Restricted stock units became fully vested and entitled to settlement immediately prior to the Merger and terminated upon settlement in shares of SCLN common stock.
/s/ Carey Chern
2017-10-16